Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Federica Zumaglini"'
Autor:
Valentina Gallà, Daniele Andreis, Federica Zumaglini, Francesca Fabbri, Emanuela Montanari, Chiara Zingaretti, Alessandra Piancastelli, Ilaria Massa, Greta Fabbri, Oriana Nanni, Monia Dall'Agata, Patrizia Serra, Giorgia Gentili, Linda Valmorri, Manuela Monti, Sara Testoni, Britt Rudnas, Bernadette Vertogen, Flavia Pagan, Angela Ragazzini
Publikováno v:
JCO oncology practice. 17(1)
PURPOSE: Cancer clinical trials (CTs) are now more complex than ever before and require dedicated personnel (clinical research coordinators [CRCs]) to perform regulatory and administrative activities and protocol- and patient-related procedures. We d
Autor:
L. Frassineti, Silvia Palazzi, Maurizio Marangolo, Barbara Kopf, Federica Zumaglini, Emiliani E, Massimo Giannini, Noemi Giovannini, Ugo De Giorgi, Giovanni Rosti
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 65:1165-1169
Purpose: To verify the feasibility of, and quantify the risk of, pneumonitis from locoregional radiotherapy (RT) after high-dose dense chemotherapy with epirubicin and paclitaxel with peripheral blood progenitor cell support in patients with high-ris
Autor:
Emanuele Naglieri, Ugo De Giorgi, Franco Testore, Giovanni Lo Re, Federica Zumaglini, Giuseppe Fornarini, Giovanni Rosti, Luciano Burattini, Michele Aieta, Maurizio Marangolo
Publikováno v:
European urology. 50(5)
Objective Cisplatin-refractory germ cell tumors (GCTs) represent a subset of germinal neoplasms with a poor prognosis. Conventional-dose chemotherapy induces objective response in 10–20% of these patients with rare durable complete remissions. We i
Autor:
Petros Giovanis, Maurizio Marangolo, Federica Zumaglini, Andrea Rossi, Giorgio Cruciani, Daniele Turci, Dino Amadori, Davide Tassinari, E. Pasquini, G. Oliverio, Ilaria Panzini, M. Nicolini, Alberto Ravaioli
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(10)
PURPOSE: A phase II trial investigated the activity and toxicity of a bolus administration schedule of oxaliplatin, fluorouracil (5-FU), and leucovorin (LV) therapy in patients with untreated advanced colorectal cancer. PATIENTS AND METHODS: Forty-fi
Autor:
Maurizio Leoni, Amelia Tienghi, Patrizia Ferrante, Livia Albertazzi, Giammaria Fiorentini, Walter Latino, Daniele Turci, Bernadette Vertogen, Federica Zumaglini, Claudio Dazzi, A. Cariello, Giovanni Rosti, Maurizio Marangolo, Antonio Maestri
Publikováno v:
Tumori. 83(6)
The use of high-dose chemotherapy followed by hematopoietic rescue is increasing worldwide for solid tumors. Several studies have suggested that the period of absolute neutrophil count (ANC
Autor:
N. Giovannini, Federica Zumaglini, Davide Tassinari, Barbara Kopf, Lorenzo Cecconetto, Laura Mercatali, E. Flamini, U. de Giorgi, Ornella Carminati, Giovanni Luca Frassineti
Publikováno v:
ResearcherID
897 Background: There is evidence to suggest that dose intensity is correlated with clinical efficacy in the treatment of patients (pts) with breast cancer. Methods: Seventy consecutive pts with st...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0055df6111d69acd5339757b619d1d8
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000230326600405&KeyUID=WOS:000230326600405
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000230326600405&KeyUID=WOS:000230326600405